BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 18695042)

  • 1. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
    Yu Z; Wang C; Wang M; Li Z; Casimiro MC; Liu M; Wu K; Whittle J; Ju X; Hyslop T; McCue P; Pestell RG
    J Cell Biol; 2008 Aug; 182(3):509-17. PubMed ID: 18695042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression.
    He J; Ge Q; Lin Z; Shen W; Lin R; Wu J; Wang B; Lu Y; Chen L; Liu X; Zheng W; Zhang Y; Wang L; Wang K; Wang L; Zhuo W; Chen S
    FASEB J; 2020 Jun; 34(6):8544-8557. PubMed ID: 32356314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ERĪ±-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.
    Liang Z; Li S; Xu X; Xu X; Wang X; Wu J; Zhu Y; Hu Z; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
    Mol Cells; 2015; 38(2):130-7. PubMed ID: 25556372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.
    Hui W; Yuntao L; Lun L; WenSheng L; ChaoFeng L; HaiYong H; Yueyang B
    PLoS One; 2013; 8(1):e54932. PubMed ID: 23383003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
    Zhang Z; Shao L; Wang Y; Luo X
    Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
    Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
    J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
    Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
    J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-937-5p targets SOX17 to modulate breast cancer cell cycle and cell proliferation through the Wnt signaling pathway.
    Xiong X; Xu W; Gong J; Wang L; Dai M; Chen G; Yuan L
    Cell Signal; 2021 Jan; 77():109818. PubMed ID: 33144185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting.
    Zhong Q; Xiong Y; Ling C; Qian Y; Zhao X; Yang H
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1297-1306. PubMed ID: 34092127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
    Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
    PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in Breast Cancer Cells.
    El-Daly SM; Gamal-Eldeen AM; Gouhar SA; Abo-Elfadl MT; El-Saeed G
    Appl Biochem Biotechnol; 2020 Dec; 192(4):1208-1223. PubMed ID: 32710170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.